A large study hints at the potential benefit of an experimental COVID-19 drug called remdesivir.

“Patients receiving a 10-day treatment course of remdesivir achieved similar improvement in clinical status compared with those taking a 5-day treatment course,” Gilead Sciences, which makes the drug, said in a press release Wednesday.

Full coverage of the coronavirus outbreak

This site is protected by recaptcha 

However, Gilead has not yet released enough information from the trial to show what that “improvement” means for patients. The company said full results would be published “in the coming weeks.”

The analysis did not compare remdesivir to a placebo, so it’s impossible to determine whether any benefits were due to the drug or whether patients would have improved on their own.

Download the NBC News app for full coverage of the coronavirus outbreak

This latest study was meant to determine how long hospitalized patients would need to be on the drug for a potential clinical benefit. If patients only need 5 days of treatment, rather than 10, it would mean Gilead could double the number of people treated.

“This is particularly important in the setting of a pandemic,” Dr. Merdad Parsey, Gilead’s chief medical officer, said in the press release.

Remdesivir is not approved by the Food and Drug Administration, has not been proven as an effective treatment for patients with the coronavirus. Studies on the drug are ongoing, and data from a National Institutes of Allergy and Infectious Diseases trial are expected later today.

This is a developing story.

Follow NBC HEALTH on Twitter & Facebook.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Asian shares advance following upbeat US jobs report

Markets advanced in Asia on Friday following a Wall Street rally driven by strong jobs data. Tokyo’s Nikkei 225 index picked up 0.3% to 22,211.89, while the Shanghai Composite index jumped 1% to 3,121.74. In South Korea, the Kospi gained…

A huge Wendy’s and Pizza Hut franchisee just filed for bankruptcy

New York (CNN Business)NPC International, the operator of 1,200 Pizza Hut and nearly 400 Wendy’s restaurants in the United States, has filed for bankruptcy. The franchisee has been dealing with a perfect storm of problems that led to its Chapter…

The man who led Wirecard into insolvency

FRANKFURT (Reuters) – On the night of June 18, Wirecard AG’s new compliance chief stayed up late at his office in the company’s low-rise headquarters in the Munich suburb of Aschheim to pore over the payment firm’s books. It was…

Dow plunges nearly 7 percent on coronavirus concerns

Markets took a dramatic dip on Thursday, as investors weighed sobering economic forecasts and new data, with indications the COVID-19 pandemic is far from subsiding. The Dow Jones Industrial Average closed down 1,861 points, or 6.9 percent and the S&P…